Bryn Pharma Revenue and Competitors

Location

$83.2M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bryn Pharma's estimated annual revenue is currently $2.1M per year.(i)
  • Bryn Pharma's estimated revenue per employee is $100,500
  • Bryn Pharma's total funding is $83.2M.

Employee Data

  • Bryn Pharma has 21 Employees.(i)
  • Bryn Pharma grew their employee count by 75% last year.

Bryn Pharma's People

NameTitleEmail/Phone
1
Co-Founder, PresidentReveal Email/Phone
2
CEOReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Strategy and Business Development OfficerReveal Email/Phone
5
VP, Head ManufacturingReveal Email/Phone
6
SVP Sales and MarketingReveal Email/Phone
7
VP and Head Human ResourcesReveal Email/Phone
8
Head Research and DevelopmentReveal Email/Phone
9
Head Human ResourcesReveal Email/Phone
10
Head Medical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Bryn Pharma?

Bryn Pharma is a privately held pharmaceutical company based in North Carolina. Primary focus is on the development and commercialization of innovative allergy products for the management of anaphylaxis. The mission of Bryn Pharma is to empower patients with a life-saving device that is small enough to comfortably fit in your pocket and easy to use in the event of an anaphylactic attack. Our intranasal delivery system will be an exciting alternative to epinephrine auto-injectors providing patients a needle-free option that is easy to use, portable, and affordable.

keywords:N/A

$83.2M

Total Funding

21

Number of Employees

$2.1M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bryn Pharma News

2022-04-06 - Inside look at Venture Connect: Snapshots of the 88 presenting startups

Bryn Pharma, LLC: Pharmaceutical company focused on developing and commercializing an alternative to epinephrine auto-injectors,...

2022-03-22 - Needle-Free Epinephrine Products Could Be Available in 2023

ARS Pharmaceuticals compared its intranasal product (Neffy 1 mg) ... Bryn Pharma compared pharmacokinetics of its nasal spray product...

2021-02-27 - Bryn Pharma Announces Presentation Of Positive Clinical Results From Multi-Dose Study Of Bi-Dose Epinephrine Nasal Spray For The Treatment Of Anaphylaxis At AAAAI Virtual Annual Meeting

RALEIGH, N.C., Feb. 27, 2021 /PRNewswire/ -- Bryn Pharma, LLC ("Bryn" or the "Company"), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, today announced positive clinical results from its multi-dose study of BRYN-NDS1C ...

2020-08-05 - Bryn Pharma Raises $11M in Financing

Bryn Pharma, LLC, a Raleigh, N.C.-based pharmaceutical company, raised an additional $11m in financing. Participants in the round, which brought the total proceeds from the transaction to $26m, included existing and new funds, family offices and private investors. The company intends to use th ...

2019-10-25 - Bryn Pharma Raises $17.5M for Epinephrine Nasal Spray

Bryn Pharma, LLC raised $17.5 million to fund government approval and the commercialization of an epinephrine nasal spray, the company announced in a press release Thursday. Bryn Intranasal Epinephrine Spray, or BRYN-NDS1C, is designed to hold two doses of epinephrine in one device, eliminating ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M21-9%N/A
#2
$2.1M215%N/A
#3
$2.1M215%N/A
#4
$2.1M21-30%N/A
#5
N/A21-50%N/A